y 27632 has been researched along with Parkinson Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bähr, M; Becker, S; Dambeck, V; Eckermann, K; Fonseca-Ornelas, L; Koch, JC; Lingor, P; Lopes da Fonseca, T; Outeiro, TF; Tatenhorst, L; Tönges, L; Walle, H; Zweckstetter, M | 1 |
| Muguruma, K; Sasai, Y; Wataya, T | 1 |
| Alessi, DR; Bamborough, P; Cantley, LC; Deak, M; Dzamko, N; Hutti, JE; Moran, J; Nichols, RJ; Reith, AD | 1 |
| Byers, B; Byrne, J; Cord, B; Dolmetsch, RE; Gujar, P; Kee, K; Langston, W; Nguyen, HN; Palmer, TD; Pera, RR; Schüle, B; Shcheglovitov, A | 1 |
| Dominguez-Meijide, A; Guerra, MJ; Joglar, B; Labandeira-Garcia, JL; Rodriguez-Perez, AI; Villar-Cheda, B | 1 |
1 review(s) available for y 27632 and Parkinson Disease
| Article | Year |
|---|---|
[Human pluripotent stem cell and neural differentiation].
Topics: Amides; Animals; Apoptosis; Cell Aggregation; Cell Culture Techniques; Cell Differentiation; Cell- and Tissue-Based Therapy; Central Nervous System; Dopamine; Embryonic Stem Cells; Enzyme Inhibitors; Humans; Mice; Parkinson Disease; Pluripotent Stem Cells; Pyridines; Regenerative Medicine; rho-Associated Kinases | 2008 |
4 other study(ies) available for y 27632 and Parkinson Disease
| Article | Year |
|---|---|
Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; alpha-Synuclein; Amides; Animals; Brain; Carrier Proteins; Cell Line, Tumor; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Humans; Mice; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Parkinson Disease; Protein Aggregates; Protein Kinase Inhibitors; Psychomotor Performance; Pyridines; Recognition, Psychology; Time Factors; Tyrosine 3-Monooxygenase | 2016 |
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Enzyme Activation; Enzyme Inhibitors; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mutation; Parkinson Disease; Phosphorylation; Protein Serine-Threonine Kinases; Protein Structure, Secondary; Pyridines; rho-Associated Kinases; Substrate Specificity | 2009 |
LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.
Topics: Amides; Amino Acid Substitution; Animals; Cell Death; Cell Differentiation; Dopamine; Female; Humans; Hydrogen Peroxide; Induced Pluripotent Stem Cells; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Leupeptins; Mesencephalon; Mice; Middle Aged; Mutation; Neurons; Oxidative Stress; Oxidopamine; Parkinson Disease; Phenotype; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases | 2011 |
Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.
Topics: Amides; Angiotensins; Animals; Cell Death; Cells, Cultured; Dopaminergic Neurons; Enzyme Inhibitors; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Parkinson Disease; Pyridines; Receptor, Angiotensin, Type 1; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction | 2012 |